Towards a Cannabinoid Hypothesis of Schizophrenia: Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid System
- 1 April 1997
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 56 (4) , 803-807
- https://doi.org/10.1016/s0091-3057(96)00426-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Dopamine receptor pharmacologyTrends in Pharmacological Sciences, 1994
- Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamenEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Psychiatric Symptoms in Cannabis UsersThe British Journal of Psychiatry, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Influence of cannabis abuse on schizophrenic psychopathologyActa Psychiatrica Scandinavica, 1992
- The Clinical Correlates of Neurological Soft Signs in Chronic SchizophreniaThe British Journal of Psychiatry, 1991
- Schizophrenia in users and nonusers of cannabisActa Psychiatrica Scandinavica, 1989
- Zur Psychopathologie und Differentialdiagnose sogenannter CannabispsychosenFortschritte der Neurologie · Psychiatrie, 1983
- Cannabis Induced PsychosisBritish Journal of Addiction to Alcohol & Other Drugs, 1970
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964